DPA26BZ05-DV020Pre-ReleaseSBIR

Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations

Department of DefenseDARPA

AI Overview

This Phase II SBIR seeks an automated, species-agnostic cell culture platform that rapidly establishes reproducible cell lines from non-model organisms—compressing years of manual optimization into weeks. The platform will enable faster gene-drive research and genetic-biocontrol development across diverse vertebrate and invertebrate species.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
Release Date
August 5, 2026
Due Date
September 23, 2026

Official Description

Cell culture is foundational to modern biotechnology, biomanufacturing, drug discovery, vaccine production, regenerative medicine, and genetic engineering. However, most established cell culture protocols, media formulations, and immortalized or pluripotent cell lines exist only for well-characterized "model" organisms (e.g., human, mouse, rat). For many vertebrate species, including those of emerging interest to defense, biosecurity, agricultural, conservation, and public-health stakeholders, n...

View on official source

Change History

Opportunity AddedAug 5, 2026 at 12:02 PM

Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations

New opportunity: Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations

Similar Opportunities

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial